Navigation Links
Promised Drug Doesn't Help Acute Heart Failure

Intravenous administration of the drug tezosentan did not improve worsening heart failure or prevent death in patients with acute heart failure // despite high hopes. The above fact was found out in the largest international trial on acute heart failure to date. The study was conducted to evaluate if something more could be done for acute heart failure patients in order to speed up hospital discharge and prevent them from coming back.

More than 1,400 acute heart failure patients received either IV administration of the endothelin receptor antagonist called tezosentan or a placebo, plus conventional therapy. Endothelin-1 is a potent vasoconstrictor produced in the blood vessels and other tissues. Its presence is a strong predictor of mortality in acute heart failure.

No difference in dyspnea, or a significant breathing problem, for the two groups of hospitalized patients over 24 hours. After a week, there was also no difference between the placebo group and group receiving tezosentan in incidence of death or worsening of heart failure. After six months, no difference was observed in overall mortality.
'"/>




Page: 1

Related medicine news :

1. Deep Sleep Doesnt Increase Memory
2. Dental Amalgam Doesnt Pose Health Risks In Children
3. Why Immune System Doesnt Attack Small Intestine?
4. Acute Measles Supresses HIV Replication
5. Severe Acute respiratory Syndrome (SARS)
6. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
7. Acute Pancreatitis On The Rise Due To Alcohol Consumption
8. Gene Fusion Test to screen children’s with Acute Lymphoblastic Leukemi
9. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
10. Acute Gastroenteritis Responds To Treatment With Either Gatorade Or Pedialyte
11. Acute Shortage Of Neurosurgeons In India: One Surgeon For Every 1 Million!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: